ARC
BLUE

Absolute Return Capital’s bluebird bio BLUE Stock Holding History

Absolute Return Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,491
Closed -$745K – 642
2014
Q2 		$745K Buy
+1,491
New +$478K 0.01% 750

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Absolute Return Capital's BLUE Position: Q3 2014 in Review

Absolute Return Capital sold out of bluebird bio (BLUE) in Q3 2014, closing a stake of 1,491 shares — an estimated $745K sold.

Absolute Return Capital first reported a position in BLUE in Q2 2014 and held it in 1 quarter. The position peaked at $745K in Q2 2014. 123 funds tracked by Wall St. Rank hold BLUE as of Q3 2014.

  • Absolute Return Capital reported no remaining bluebird bio position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 1,491 bluebird bio shares in Q3 2014, an estimated $745K.
  • Absolute Return Capital first reported a position in bluebird bio in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's bluebird bio position peaked at $745K in Q2 2014.
  • 123 funds tracked by Wall St. Rank held bluebird bio as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.